A Critical Imperative: Diversifying Hepatocellular Carcinoma Research Through Increased Participation of People of Color

Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, represents a significant global health challenge. While research into the etiology, pathogenesis, and treatment of HCC has advanced considerably, a critical gap persists: the underrepresentation of people of color in HCC research. This disparity has profound implications for understanding disease heterogeneity, developing effective prevention strategies, and delivering equitable healthcare to all populations affected by this devastating disease. This article highlights the pressing need for increased participation of people of color in HCC research and explores the multifaceted reasons why this diversification is crucial.